Literature DB >> 19268650

Binding and stabilization of transthyretin by curcumin.

Raghu Pullakhandam1, P N B S Srinivas, Madhavan K Nair, G Bhanuprakash Reddy.   

Abstract

Biophysical evidences suggest that transthyretin (TTR) tetramer dissociation to the monomeric intermediate and subsequent polymerization leads to amyloid fibril formation, which is implicated in the pathogenesis of familial amyloid polyneuropathy (FAP) and senile systemic amyloidosis (SSA). Hence, inhibition of fibril formation is considered a potential therapeutic strategy. Here in we demonstrate that curcumin, a phenolic constituent of curry spice turmeric, binds to the active site of TTR through fluorescence quenching and ANS displacement studies. Binding of curcumin appears to inhibit the denaturant induced tertiary and quaternary structural changes in TTR as monitored by intrinsic emission fluorescence and glutaraldehyde cross-linking studies. However, curcumin did not bind to TTR at acidic pH. Protonation/ isomerization of the side chain oxygen atoms of curcumin at low pH might hamper the binding. These results suggest that curcumin binds to and stabilizes TTR thereby highlight the importance of the side chain conformations of the ligand in binding to TTR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268650     DOI: 10.1016/j.abb.2009.02.013

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

Review 1.  Degradation of Curcumin: From Mechanism to Biological Implications.

Authors:  Claus Schneider; Odaine N Gordon; Rebecca L Edwards; Paula B Luis
Journal:  J Agric Food Chem       Date:  2015-04-02       Impact factor: 5.279

2.  Designed Trpzip-3 β-Hairpin Inhibits Amyloid Formation in Two Different Amyloid Systems.

Authors:  Gene Hopping; Jackson Kellock; Byron Caughey; Valerie Daggett
Journal:  ACS Med Chem Lett       Date:  2013-08-01       Impact factor: 4.345

Review 3.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

4.  Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites.

Authors:  Paola Florio; Claudia Folli; Michele Cianci; Daniele Del Rio; Giuseppe Zanotti; Rodolfo Berni
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 5.  Multitargeting by curcumin as revealed by molecular interaction studies.

Authors:  Subash C Gupta; Sahdeo Prasad; Ji Hye Kim; Sridevi Patchva; Lauren J Webb; Indira K Priyadarsini; Bharat B Aggarwal
Journal:  Nat Prod Rep       Date:  2011-10-06       Impact factor: 13.423

Review 6.  Novel pharmacotherapies for cardiac amyloidosis.

Authors:  Kevin M Alexander; Avinainder Singh; Rodney H Falk
Journal:  Pharmacol Ther       Date:  2017-06-22       Impact factor: 12.310

7.  Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation.

Authors:  Vidyullatha Vasireddy; Venkata R M Chavali; Victory T Joseph; Rajendra Kadam; Jonathan H Lin; Jeffrey A Jamison; Uday B Kompella; Geereddy Bhanuprakash Reddy; Radha Ayyagari
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

8.  Discovery of γ-Mangostin as an Amyloidogenesis Inhibitor.

Authors:  Takeshi Yokoyama; Mitsuharu Ueda; Yukio Ando; Mineyuki Mizuguchi
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.996

Review 9.  Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure.

Authors:  Traci L Parry; Jason H Melehani; Mark J Ranek; Monte S Willis
Journal:  Front Cardiovasc Med       Date:  2015-05-19

Review 10.  Protein folding and aggregation into amyloid: the interference by natural phenolic compounds.

Authors:  Massimo Stefani; Stefania Rigacci
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.